Mi Ra Kim

This inventor holds 4 USPTO granted patents and 1 published patent application, plus 2 CIPO patents and 3 EPO patents. Top assignees: Hanmi Science Co., Ltd., Hanmi Holdings Co., Ltd.. Active years: 2012-2017.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Mi Ra Kim. Retrieved from https://idiyas.com/inventor/mi-ra-kim

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 4 (Patent Applications = 1)

% Patents Active = 100.0

CIPO Patents = 2 (Patent Applications = 1)

EPO Patents = 3 (Patent Applications = 3)

Average Co-Inventor Count = 11.8

ph-index = 3

Forward Citations = 21(Granted Patents)

Company Filing History:

3 out of 63

Hanmi Science Co., Ltd.

patents

1 out of 12

Hanmi Holdings Co., Ltd.

patents

Years Active: 2012-2017

Loading Chart...

4 patents (USPTO):Sort by Forward CitationsExplore Patents

1. RE46511 - Fused pyrimidine derivatives for inhibition of tyrosine kinase activity (2017-08-14),

2. 9345719 - Fused pyrimidine derivatives for inhibition of tyrosine kinase activity (2016-05-24),

3. 8957065 - Fused pyrimidine derivatives for inhibition of tyrosine kinase activity (2015-02-17),

4. 8188102 - Amide derivative for inhibiting the growth of cancer cells (2012-05-29),

Title: Mi Ra Kim: Innovator in Pharmaceutical Chemistry

Introduction

Mi Ra Kim is a prominent inventor based in Seoul, South Korea. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel compounds for medical applications. With a total of four patents to his name, Kim's work focuses on innovative solutions for treating various diseases.

Latest Patents

Among his latest patents, Mi Ra Kim has developed fused pyrimidine derivatives that inhibit tyrosine kinase activity. This invention relates to a novel fused pyrimidine derivative that exhibits inhibitory activity for tyrosine kinases. The pharmaceutical composition derived from this invention is aimed at preventing or treating cancers, tumors, inflammatory diseases, autoimmune diseases, or immunologically mediated diseases.

Career Highlights

Throughout his career, Mi Ra Kim has worked with notable companies such as Hanmi Science Co., Ltd. and Hanmi Holdings Co., Ltd. His experience in these organizations has allowed him to refine his expertise in pharmaceutical development and innovation.

Collaborations

Mi Ra Kim has collaborated with several professionals in his field, including Mi Young Cha and Maeng Sup Kim. These collaborations have contributed to the advancement of his research and the successful development of his patented inventions.

Conclusion

Mi Ra Kim stands out as an influential inventor in the realm of pharmaceutical chemistry. His innovative work on fused pyrimidine derivatives showcases his commitment to advancing medical treatments and improving patient outcomes.

Profile summary based on public USPTO records.